scientific Sessions

Molecular Imaging Agents for Cancer

Molecular imaging agents are specialized compounds that enhance the visualization of cancerous tissues during diagnostic imaging. These agents target specific biomarkers or molecular pathways associated with tumors, allowing for precise cancer detection, staging, and monitoring. At the Cancer Research and Development Conference 2025, we will explore how innovations in radiotracers, fluorescent probes, and nanoparticle-based agents revolutionize cancer imaging. This allows for earlier diagnosis and guides personalized treatment approaches, ensuring better patient outcomes.

Related Sessions

Advances in Nanotechnology for Cancer Treatment
Cellular Therapies Beyond CAR-T
The Role of Epigenetics in Cancer Diagnosis
Cancer Genomics and Epigenomics
Liquid Biopsy Innovations
Immunomodulatory Molecules in Cancer Therapy
Pediatric Oncology
Advances in Cancer Genetics and Genomics
Novel Cancer Vaccines
Systems Biology in Cancer Research
Cutting-Edge Therapies in Cancer Treatment
Tumour Suppressor Molecules in Cancer Therapy
Molecular Imaging Agents for Cancer
Organoids and 3D Bioprinting in Cancer R&D
Don't miss our future updates!

Get in Touch